BRAF and neoplasm: Concerning SA, as described above, there are very few studies about the role of this secretory pathway in BRAF melanomas and we believe that this route may induce resistance not only in tumor cells, but it can also reprogram other stromal cells present in the TME through the secretion of important pro-tumoral molecules.